영양, 대사 및 감염에 미치는 프로톤펌프억제제의 영향: Safe 측면 = Special Review : The Effect of Proton Pump Inhibitors on Nutrition, Metabolism, Infection and Small Intestinal Bacterial Overgrowth: Safe Perspective

다국어 초록 (Multilingual Abstract)

Proton pump inhibitors (PPIs) have been widely used to treat patients with acid-related disorders because they are perceived to besafe and effective. However, they have the potential for side effects. Many studies have examined the side effects of long-term PPI exposure. We review the side effects of long-term PPIs, focusing on nutrition, metabolism, and infection. (Korean J Med 2011;81:11-16)

참고문헌 (Reference)

1 Howden CW, "Vitamin B12 levels during prolonged treatment with proton pump inhibitors" 30 : 29-33, 2000

2 Ruscin JM, "Vitamin B(12) deficiency associated with histamine(2)-receptor antagonists and a protonpump inhibitor" 36 : 812-816, 2002

3 Gulmez SE, "Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study" 167 : 950-955, 2007

4 Targownik LE, "Use of proton pump inhibitors and risk of osteoporosis-related fractures" 179 : 319-326, 2008

5 Mitchell SL, "The association between antiulcer medication and initiation of cobalamin replacement in older persons" 54 : 531-534, 2001

6 Theisen J, "Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids" 4 : 50-54, 2000

7 Kantorova I, "Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial" 51 : 757-761, 2004

8 Cundy T, "Severe hypomagnesaemia in long-term users of proton-pump inhibitors" 69 : 338-341, 2008

9 Koop H, "Serum iron, ferritin, and vitamin B12 during prolonged omeprazole therapy" 14 : 288-292, 1992

10 Thomson AB, "Safety of the long-term use of proton pump inhibitors" 16 : 2323-2330, 2010

11 Yang YX, "Safety of proton pump inhibitor exposure" 139 : 1115-1127, 2010

12 Williams C, "Review article: proton pump inhibitors and bacterial overgrowth" 23 : 3-10, 2006

13 Epstein M, "Proton-pump inhibitors and hypomagnesemic hypoparathyroidism" 355 : 1834-1836, 2006

14 Sarkar M, "Proton-pump inhibitor use and the risk for community-acquired pneumonia" 149 : 391-398, 2008

15 Richards JB, "Proton pump inhibitors: balancing the benefits and potential fracture risks" 179 : 306-307, 2008

16 Corley DA, "Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients" 139 : 93-101, 2010

17 Laine L, "Proton pump inhibitors and bone fractures" 104 (104): S21-S26, 2009

18 Geller JL, "Proton pump inhibitor therapy and hip fracture risk" 297 : 1429-, 2007

19 Yildizdas D, "Occurrence of ventilatorassociated pneumonia in mechanically ventilated pediatric intensive care patients during stress ulcer prophylaxis with sucralfate, ranitidine, and omeprazole" 17 : 240-245, 2002

20 den Elzen WP, "Long-term use of proton pump inhibitors and vitamin B12 status in elderly individuals" 27 : 491-497, 2008

21 Maton PN, "Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: a prospective study" 97 : 827-836, 1989

22 Stewart CA, "Iron absorption in patients with Zollinger-Ellison syndrome treated with long-term gastric acid antisecretory therapy" 12 : 83-98, 1998

23 Lombardo L, "Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy" 8 : 504-508, 2010

24 Kuipers MT, "Hypomagnesaemia due to use of proton pump inhibitors: a review" 67 : 169-172, 2009

25 Mackay JD, "Hypomagnesaemia due to proton-pump inhibitor therapy: a clinical case series" 103 : 387-395, 2010

26 Moayyedi P, "Hip fracture and proton pump inhibitor therapy: balancing the evidence for benefit and harm" 103 : 2428-2431, 2008

27 Aseeri M, "Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients" 103 : 2308-2313, 2008

28 Pépin J, "Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec" 41 : 1254-1260, 2005

29 Schenk BE, "Effect of short- and long-term treatment with omeprazole on the absorption and serum levels of cobalamin" 10 : 541-545, 1996

30 Sharma VR, "Effect of omeprazole on oral iron replacement in patients with iron deficiency anemia" 97 : 887-889, 2004

31 Termanini B, "Effect of long-term gastric acid suppressive therapy on serum vitamin B12 levels in patients with Zollinger-Ellison syndrome" 104 : 422-430, 1998

32 Levy MJ, "Comparison of omeprazole and ranitidine for stress ulcer prophylaxis" 42 : 1255-1259, 1997

33 Wolters M, "Cobalamin: a critical vitamin in the elderly" 39 : 1256-1266, 2004

34 Kapadia C, "Cobalamin (Vitamin B12) deficiency: is it a problem for our aging population and is the problem compounded by drugs that inhibit gastric acid secretion" 30 : 4-6, 2000

35 Thorens J, "Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study" 39 : 54-59, 1996

36 Spiegel BM, "Bacterial overgrowth and irritable bowel syndrome: unifying hypothesis or a spurious consequence of proton pump inhibitors" 103 : 2972-2976, 2008

37 Schenk BE, "Atrophic gastritis during long-term omeprazole therapy affects serum vitamin B12 levels" 13 : 1343-1346, 1999

38 Sultan N, "Association between proton pump inhibitors and respiratory infections: a systematic review and meta-analysis of clinical trials" 22 : 761-766, 2008

39 Kahrilas PJ, "American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease" 135 : 1392-1413, 2008

40 Lewis SJ, "Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole" 10 : 557-561, 1996

41 Yamanaka Y, "A study of 13 patients with gastric tube in place after esophageal resection: use of omeprazole to decrease gastric acidity and volume" 13 : 370-373, 2001

42 Hoorn EJ, "A case series of proton pump inhibitor-induced hypomagnesemia" 56 : 112-116, 2010